Celyad Oncology SA

Celyad Oncology SAverified

0QFK.L

Price:

$0.8

Market Cap:

$17.11M

Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical trial to treat relapsed / refractory multiple myeloma; and CYAD-02, an autologous CAR-T candidate that is in Phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes. The company's precl...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2014-01-08

Stock Exchange

LSE

Ticker

0QFK.L

0QFK.L Dividend History Overview

Dividends are a key part of long-term returns for investors, and Celyad Oncology SA (0QFK.L) has a track record worth reviewing. Looking at dividend history for 0QFK.L gives you an idea of how consistent the dividends have been and what you might expect in the future.

Ex-Dividend Date

2022-03-15

Dividend Yield

0%

Annual Dividend

$0.28

P/E Ratio

-0.55

Payout Ratio

0

Dividend per Share

$0

EPS

-1.44

Ex-Date/EFF DateDividend AmountAdjusted DividendPayment DateDeclaration Date
2022-03-15$0.285$0.285

Celyad Oncology SA (0QFK.L) Dividend History Chart

The table below shows Celyad Oncology SA (0QFK.L) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.

Celyad Oncology SA (0QFK.L) Dividend Growth

Celyad Oncology SA (0QFK.L) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.

Other Popular Dividend Stocks

Check out the dividend history of other popular stocks:

Stock nameDividend yield

Track & Identify Dividend Stocks

Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.

Custom stock screener in Wisesheets

You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Celyad Oncology SA (0QFK.L) without the pain and hassle of copy pasting data.

Custom stock screener in Wisesheets

Frequently asked questions❓

What is dividend history?

How do I check past dividend history?

What does the ex-dividend date mean?

What is 0QFK.L’s dividend yield?

What is the difference between regular and special dividends?

Has 0QFK.L increased its dividends over time?

Why might dividend history data be delayed?

How often does 0QFK.L pay dividends?

What factors impact 0QFK.L's dividend payments?

Can dividends change over time?

What is 0QFK.L’s next dividend date?